학술논문
The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): a multicentre, double-blind, randomised controlled trial
Document Type
Article
Author
Tarnow-Mordi, William O; Abdel-Latif, Mohamed E; Martin, Andrew; Pammi, Mohan; Robledo, Kristy; Manzoni, Paolo; Osborn, David; Lui, Kei; Keech, Anthony; Hague, Wendy; Ghadge, Alpana; Travadi, Javeed; Brown, Rebecca; Darlow, Brian A; Liley, Helen; Pritchard, Margo; Kochar, Anu; Isaacs, David; Gordon, Adrienne; Askie, Lisa; Cruz, Melinda; Schindler, Tim; Dixon, Kelly; Deshpande, Girish; Tracy, Mark; Schofield, Deborah; Austin, Nicola; Sinn, John; Simes, R John; Black, R.; Nie, W.; Reid, S.; Michalowski, J.; McKeown, L.; Koorts, P.; Broom, M.; Kwan, P.; Morris, S.; Cornthwaite, K.; Tobiansky, R.; Darcy, D.; Goodchild, L.; Collins, C.; Noble, E.; Lewis, A.; Yeomans, E.; Hua, C.; Hinder, M.; Bhaskaracharya, A.; Graham, P.; Patel, H.; Wilkes, N; Marlow, N.; Soll, R.; McKinlay, C.; Modi, N.; Marschner, I.; Stenson, B.; Espinoza, D.
Source
The Lancet Child & Adolescent Health; June 2020, Vol. 4 Issue: 6 p444-454, 11p
Subject
Language
ISSN
23524642; 23524650
Abstract
Very low birthweight or preterm infants are at increased risk of adverse outcomes including sepsis, necrotising enterocolitis, and death. We assessed whether supplementing the enteral diet of very low-birthweight infants with lactoferrin, an antimicrobial protein, reduces all-cause mortality or major morbidity.